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ABSTRACT
Macrophages (MPs) exert either beneficial or deleterious
effects on tissue repair, depending on their activation/
polarization state. They are crucial for adult skeletal mus-
cle repair, notably by acting on myogenic precursor cells.
However, these interactions have not been fully character-
ized. Here, we explored both in vitro and in vivo, in
human, the interactions of differentially activated MPs
with myogenic precursor cells (MPCs) during adult myo-
genesis and skeletal muscle regeneration. We showed in
vitro that through the differential secretion of cytokines
and growth factors, proinflammatory MPs inhibited MPC
fusion while anti-inflammatory MPs strongly promoted
MPC differentiation by increasing their commitment into
differentiated myocytes and the formation of mature myo-
tubes. Furthermore, the in vivo time course of expression
of myogenic and MP markers was studied in regenerating
human healthy muscle after damage. We observed that
regenerating areas containing proliferating MPCs were
preferentially associated with MPs expressing proinflam-
matory markers. In the same muscle, regenerating areas
containing differentiating myogenin-positive MPCs were
preferentially coupled to MPs harboring anti-inflamma-
tory markers. These data demonstrate for the first time in
human that MPs sequentially orchestrate adult myogenesis
during regeneration of damaged skeletal muscle. These
results support the emerging concept that inflammation,
through MP activation, controls stem cell fate and coordi-
nates tissue repair. STEM CELLS 2013;31:384–396
Disclosure of potential conflicts of interest is found at the end of this article.
INTRODUCTION
Macrophages (MPs) are one of the main agents of innate immu-
nity. They contribute to the host defense and phagocytosis of
undesirable pathogens or tissue debris. As a consequence, MPs
are mainly considered as ‘‘inflammatory’’ cells that are deleteri-
ous for the tissue and efforts are focused on decreasing or pre-
venting their presence in the tissue. Indeed, several studies have
shown that MPs enhance tissue damage. For example, MP
depletion prevents or reduces the clinical signs of experimental
autoimmune neuritis [1] or attenuates blood-nerve barrier disin-
tegration during chronic nerve injury [2]. MP depletion is also
beneficial in the case of pulmonary and hepatic injury induced
by toxicants [3]. As the effects of MPs can be either beneficial
or deleterious [4–6], depending on the concentration of MP su-
pernatant used (for in vitro studies) or the time point when MP
depletion is induced (in vivo models), it is clear that the actions
of MPs are complex. In support of this, several studies have
demonstrated beneficial roles for MPs in the context of tissue
homeostasis and repair. For example, MP-secreted factors have
been reported to promote the survival, regeneration and neurite
extension of neurons [7–9], proliferation of hepatocytes [10],
and skeletal muscle regeneration [11–13].
The multiplicity of MP effects is likely due to their
inflammatory profile or state of activation. Indeed, MPs adopt
various inflammatory profiles depending on their environment.
To help in understanding these various phenotypes, MPs have
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been classified into four main subtypes [14, 15]. Proinflamma-
tory or classically activated or M1 MPs are induced by TH1
cytokines. They secrete proinflammatory cytokines and reactive
oxygen species and exhibit microbicidal and tumoricidal activ-
ities. Alternatively activated or M2a MPs are triggered by TH2
cytokines such a interleukin (IL)-4. These cells secrete a battery
of specific markers (YM1, AMCase, and Arginase 1 [Arg1]),
are associated with extracellular matrix synthesis, angiogenesis,
and parasite containment, and are observed during chronic fi-
brosis. Regulatory or M2b MPs are induced by a combination
of Toll-like receptor ligands and immune complexes and
dampen inflammation. Anti-inflammatory or deactivated or
M2c MPs are induced by anti-inflammatory compounds (e.g.,
IL-10 and glucocorticoids). They secrete anti-inflammatory
cytokines such as IL-10 and transforming growth factor
(TGF)b. Harboring different phenotypes, it is likely that the
activated/polarized MPs exhibit various functions during innate
immunity. Very few studies have explored their functions on
progenitor cells. Interferon (IFN)c- and tumor necrosis factor
(TNF)a-stimulated microglia blocks differentiation of adult
neural progenitor cells while microglia activated by IL-4 or low
levels of IFNc stimulates these neural progenitor cells toward
oligodendrogenesis and neurogenesis, respectively [16]. In
skeletal muscle, we have shown that lipopolysaccharide (LPS)/
IFNc-activated MPs stimulate myogenic cell proliferation while
IL-4 and IL-10-activated MPs support their differentiation [11].
Although MP activation states have been clearly defined in
vitro, the link between the activation states of MPs and their
functions remains unknown for most in vivo situations.
Adult skeletal muscle regeneration is an excellent para-
digm of sterile inflammation with complete resolution. While
the exact time course of human skeletal muscle regeneration
has not been determined due to the restrictions of being able
to sample human muscle a limited number of times using the
biopsy technique, the time it takes for regeneration to be com-
pleted is known to vary depending on the nature of the exper-
imental model used. For example, it has been shown that
models of acute muscle damage using neuromuscular electri-
cal stimulation, in contrast to voluntary contractions, are
required if the goal is to induce damage and regeneration,
clearly observable by signs such as infiltration of MPs into
the myofibers, activation and proliferation of satellite cells,
and the presence of myofibers positive for embryonic myosin
[17–20]. With regard to the time course of human muscle
regeneration, studies aiming to examine the endpoint are
sparse, with one recent study demonstrating ongoing regenera-
tion of the myofibers and remodeling of the extracellular ma-
trix as late as 30 days after a single bout of electrical stimula-
tion [17]. Several studies have demonstrated the presence of
damaged fibers from a range of 2–7 days post-trauma [19–
21], confirming the complexity of the sequence of events
required for successful and complete regeneration of damaged
skeletal muscle. From the few studies investigating muscle
regeneration in humans, thus, it appears that biopsy sampling
approximately 7 and 30 days post-trauma would be suitable
time points for studying processes of inflammation and satel-
lite cell activity during skeletal muscle tissue repair.
In vivo experiments in mouse have shown that MPs are
very important for muscle repair [22]. A sequential involve-
ment of proinflammatory and alternatively activated/anti-
inflammatory MPs has been delineated in this process. The
first appearing proinflammatory MPs enter into the damaged
muscle, and a few days later, they convert into anti-inflamma-
tory MPs [11]. Meanwhile, the main muscle stem cells, satel-
lite cells, undergo adult myogenesis through several sequential
steps, each of which must be correctly completed to accom-
modate successful achievement of the subsequent steps. This
process begins with the activation of the quiescent satellite
cells on the myofiber by a damage signal. Activated myogenic
precursor cells (MPCs) proliferate and it is believed that most of
them enter into terminal myogenic differentiation, while a subset
returns to quiescence to self-renew the satellite cell pool [23].
Adult myogenesis encompasses: (a) activation of quiescent satel-
lite cells and expansion of MPCs; (b) the commitment of MPCs
into terminal differentiation. This requires cell-cycle withdrawal
and expression of the myogenic program including the expres-
sion of the myogenic regulatory factors myogenin and MRF4
and contractile proteins such as myosins; (c) the migration of the
cells toward each other to establish cell/cell contacts; and (d) the
fusion of the cells into plurinucleated and contractile structures
that form myotubes in vitro and myofibers in vivo.
In this work, we studied for the first time in human the
relationship between the inflammatory profile of MPs and
their regulatory role on the homeostasis of MPCs. We
explored using human coculture in vitro which steps of adult
myogenesis are controlled by differentially activated MPs and
analyzed the involvement of a series of MP-secreted effectors.
In vivo, we investigated in parallel the kinetics of adult myo-
genesis and the presence of MP subtypes during human skele-
tal muscle regeneration.
MATERIALS AND METHODS
Human MPC Culture
Human MPCs were isolated from normal adult skeletal muscle
sample according to the French legislation (protocol registered at
the Agence de la Biomedecine in 2007 ‘‘Interrelations entre les
cellules souches adultes du muscle strie squelettique et les mac-
rophages’’ and Cochin Hospital Cell Bank, Paris, agreement n
DC-2009-944). Cells were obtained and cultured as previously
described [24] in HAMF12 medium (Gibco, Life Technologies,
Grand Island, NY http://www.lifetechnologies.com) containing
15% fetal bovine serum (FBS) and were sorted before the first
passage with anti-CD56 magnetic beads (Miltenyi Biotec, Ber-
gisch Gladbach, Germany, http://www.miltenyibiotec.com)
according to the manufacturer instructions. The purity of the
cells was assessed for CD56 expression (555518 BD Pharmin-
gen, Franklin Lakes, NJ http://www.bdbiosciences.com) by flow
cytometry (FC500 Beckman Coulter cytometer, Villepinte,
France, http://www.beckmancoulter.com).
Human MP Culture
MPs were obtained from human Buffy-coat (purchased from
Etablissement Francais du Sang according to INSERM-EFS
agreement number C CPSL UNT n 09/EFS/024) as previously
described [11, 25]. MPs seeded in 12-well plates (36,000 cells
per square centimeter) were activated/polarized for 2–3 days
into M1 MPs with 1 lg/ml LPS and 10 ng/ml IFNc, into M2c
MPs with 10 ng/ml IL-10 and 80 ng/ml dexamethasone, or into
M2a MPs with 10 ng/ml IL-4. Cells were then extensively
washed (four times) with serum-free medium to remove the
effectors. Conditioned media were obtained by incubating MPs
for 24 hours in advanced RPMI 1640 medium (Gibco) contain-
ing 0.5% FBS. Analysis of surface antigen expression was per-
formed by flow cytometry. Activated MPs were detached by
nonenzymatic dissociation solution (Sigma-Aldrich, St. Louis,
MO, http://www.sigmaaldrich.com) and gently scraped before
being incubated with anti-CD16, HLA-DR, CD80, CD206, and
CD163 antibodies (BD Pharmingen).
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In Vitro Myogenesis
MPCs were seeded on glass coverslips at 12,000 cells per
square centimeter and incubated with or without MP-condi-
tioned medium for 3 days. In some experiments (Fig. 1),
MPCs were seeded on activated MPs. In other experiments
(Fig. 5), blocking antibodies were added at the time of addi-
tion of MP-conditioned medium. Antibody concentrations
were chosen based on the ID50 according to the manufacturer
and the concentration of secreted effectors by MPs, if known,
from the literature: anti-TNFa 1/100 and 1/1,000, anti-IL-1b
1/200, anti-TGFb 1/200, anti-IL-13 1/100 (Abcam, Cam-
bridge, UK, http://www.abcam.com/), anti-Vascular Endothe-
lial Growth Factor (VEGF) 1/200, anti-IL-6 1/100, anti-
TWEAK 1/100 (R&D, Minneapolis, MN, http://www.rndsys-
tems.com/) [11, 26-28].
Commitment into Myocytes
MPCs were seeded on glass coverslips at low density (500
cells per square centimeter). In this condition, contact
between MPCs was minimal, so they could not fuse. MP-con-
ditioned medium was then added and the cells were cultured
for 72 hours.
Myogenic Fusion
MPCs were differentiated into myocytes for 3 days. These
differentiated cells were seeded at high density: 50,000 cells
per square centimeter, in 96-well plates. In this condition, the
differentiation process and migration events were prevented.
MP-conditioned medium was added and cells were further
cultured for 72 hours.
Immunolabelings
Cells were labeled with anti-desmin (Ab32362 Abcam) and
anti-myogenin (556358 BD Pharmingen) primary antibodies,
revealed by Cy3- and biotinylated-conjugated secondary anti-
bodies and streptavidin-DTAF (Jackson Immunoresearch,
West Grove, PA, http://www.jacksonimmuno.com/, Vector
Laboratories, Burlingame, CA, http://www.vectorlabs.com/).
Each experiment was repeated at least three times with differ-
ent primary cultures and performed in triplicate. Approxi-
mately five to seven pictures (20 magnification) were taken
from the triplicates, in order that approximately 200–400 (low
cell density) or 1,000 (high cell density) cells were counted
per condition per experiment. Differentiation was measured as
the number of myogenin-positive nuclei divided by the total
number of nuclei. The number of myotubes (cells containing
two or more nuclei) was expressed as a percentage of the
total cell number (Figs. 1, 5). Fusion index was the number
of nuclei within myotubes divided by the total number of
nuclei (Fig. 4). Myotubes were also classified according to
the number of myonuclei they contained and their distribution
was expressed as a percentage of the total number of myo-
tubes (Fig. 4).
MPC Motility
MPCs were seeded in 24-well plates at 1,500 cells per square
centimeter, MP-conditioned medium was added and cells
were imaged every 30 minutes for 16 hours using a Zeiss
Axiovert 200 (Oberkochen, Germany, https://www.zeiss.com/).
Cell velocity was calculated using Image J software with the
Manual Tracking plug-in. Approximately 50 cells were ana-
lyzed per condition per experiment.
MPC Migration
Migration was performed using two chambers Ibidi inserts
(Ibidi GmbH, Martinsried, Germany, http://ibidi.com/). One
Figure 1. MPs exert their effect on in vitro myogenesis through the
delivery of soluble factors. Myogenic precursor cells (MPCs) were cocul-
tured with M1 MPs, M2a MPs, or M2c MPs (black bars) or were cultured
with or without conditioned medium from the same activated MPs (white
bars) and grown for 3 days. MPCs were immunolabeled for desmin and
myogenin and the number of desminpos myogeninpos (A) and of myotubes
(B) was calculated as a percentage of desminpos cells. Results are means6
SEM of three independent experiments. (C): Examples of desmin (red)
and myogenin (green) labelings in MPCs cocultured with MPs or treated
with MP-conditioned media for 3 days. Blue ¼ Hoechst. Bar ¼ 50 lm. *,
p < .05 versus M1 MPs, #, p < .05 versus none. Abbreviation: MP,
macrophage.
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chamber was filled with 4,500 MPCs in growth medium. The
second chamber was seeded with 25,000 MPs. MPs were acti-
vated for 3 days. The silicone walls of the device were
removed and cells were cultured in advanced RPMI medium
containing 0.5% FBS. The gap between the two cell types
was imaged at time 0 and 24 hours. The distance that each
cell had moved into the gap was analyzed using Image J soft-
ware. Approximately 100 cells were analyzed per condition
per experiment.
Human Muscle Samples
The human muscle biopsy sampling study was approved by
the Regional Scientific Ethical Committees of Copenhagen in
Denmark (Ref: HD-2008-074) and conformed to the standards
set by the Declaration of Helsinki. Volunteers gave written
informed consent before inclusion. Three young healthy
untrained men (mean 6 SD, age 25 6 2 years; height 182 6
6 cm; weight 80 6 4 kg) participated in the study. Briefly, the
exercise protocol used 10 sets of 20 maximal voluntary length-
ening contractions of the quadriceps muscles, performed on an
isokinetic dynamometer (KinCom KC125AP, Chattanooga
Group Inc., Chattanooga TN, http://www.chattmed.com). Maxi-
mal percutaneous electrical stimulation was delivered to the
vastus lateralis muscle during the contraction by a handheld
stimulator (Elpha II 3000, Danmeter, Odense, Denmark, http://
www.danmeter.dk/). Muscle biopsies were obtained from the
stimulated vastus lateralis on days 7 and 30 after the exercise
protocol. A biopsy was also collected from the nonexercised
leg on day 0 as a control. Muscle biopsies were collected under
local anesthesia (1% lidocaine) with a Bergstrom biopsy nee-
dle. After collection of the specimen, the fibers were aligned,
embedded in Tissue-Tek (Sakura Finetek Europe, AJ Alphen
aan den Rijn The Netherlands, http://www.sakuraeu.com/), and
frozen by immersion in isopentane, precooled by liquid nitro-
gen. Samples were stored at 80C. For each biopsy, 10 serial
transverse sections (10 lm) were cut at 24C using a cryostat
and transferred onto SuperFrost Plus glass slides (Menzel-
Gl€aser, Braunschweig, Germany, http://www.menzel.de/).
Human Muscle Immunolabelings
Serial sections of human muscle were treated for hematoxylin
and eosin (H&E) staining or stained with antibodies raised
against the following molecules: CD56 1/100 (347740; Becton
Dickinson), ki67 1/200 (CP249; Biocare Medical, Pike Lane
Concord, CA, http://www.biocare.net/), myogenin 1/50 (F5D;
Developmental Studies Hybridoma Bank, Iowa City, Iowa,
http://dshb.biology.uiowa.edu/), Pax7 1/100 (MO15020; Neuro-
mics, Edina, MN, http://www.neuromics.com/), CD68 1/100
(ab955 Abcam), iNOS 1/25 (ab15323 Abcam), CD206 1/50
(ab8918 Abcam), CD163 1/500 (sc-20066 Santa Cruz, CA,
http://www.scbt.com/), Arg 1 1/25 (sc-18355 Santa Cruz), and
Cyclooxygenase (Cox2) 1/25 (ab2372 Abcam), revealed by
FITC- or Cy3-conjugated secondary antibodies (Jackson Immu-
noresearch). Pictures were taken with a Zeiss Axio observ-
er.Z1. The slide was scanned with a tile scan camera that auto-
matically collects overlapping focal stacks and processes them
to reconstitute the entire muscle section. To confirm coexpres-
sion of CD68 labeling with proinflammatory or anti-inflamma-
tory markers, pictures were taken with an sp2 confocal micro-
scope Leica TCS SP2 AOBS with a 1-lm depth.
Scoring Inflammation and Myogenesis in Human
Regenerating Muscle
Calculations were made at day 7 postelectrostimulation. Postin-
jury regeneration was visible at the myofiber level. Discrete
‘‘regenerating areas’’—corresponding to necrotizing/regenerating
myofibers—which contained either CD56poski67pos or myogeninpos
cells, were quantified and evaluated for all the stainings. Zones
containing numerous neighboring regenerating myofibers were
excluded to avoid confusion along the 10 serial sections. A total of
250 of regenerating areas was counted from three different biop-
sies. For each regenerating area, the number of cells positive for
CD56, myogenin, ki67, CD68/iNOS, CD68/Cox2 (COX2), CD68/
Arg1, CD206, and CD163 was evaluated.
Statistics
All in vitro experiments were performed at least three times
using independent MP and MPC primary cultures. In vivo
analyses have been performed on three different subjects.
Results are expressed as mean 6 SEM. Means were com-
pared using t test or ANOVA for statistical analyses. p < .05
was considered significant.
RESULTS
Human MPC cultures were used in the in vitro study. More
than 97% of these cells expressed CD56, a canonical marker
for myogenic cells in human (supporting information Fig.
S1). After an expansion phase during which they proliferate,
the majority of human MPCs enter into terminal differentia-
tion and express myogenin [29]. A subset of 15%–20% of
MPCs returns to quiescence to constitute a reservoir [29, 30].
Differentiation is associated with migration of the cells into
‘‘areas’’ where fusion takes place [31]. As previously shown,
human MP activation triggers specific inflammatory profiles:
M1 MPs secrete high levels of TNFa and IL-1b [11]. Flow
cytometry analysis revealed that, as expected, M1 MPs
expressed high levels of the costimulatory antigen CD80,
M2a MPs expressed CD206, and M2c MPs expressed CD163.
However, M2c MPs also expressed high levels of CD206
(supporting information Fig. S1).
Polarized MPs Exert Their Effect on MPCs
Through Soluble Factors
We checked whether the effects of activated/polarized MPs
were triggered by soluble factors or whether contact between
the two cell types was essential for the regulation of myogene-
sis. MPCs were either cocultured with MPs or treated with
MP-conditioned medium for 3 days, and expression of myoge-
nin and fusion of the cells were measured as final outcomes of
in vitro myogenesis. Figure 1 shows that M1 MPs slightly
decreased cell fusion (p < .05) while M2a MPs and M2c MPs
stimulated both the expression of myogenin (Fig. 1A, 1C) and
myotube formation (both p < .05) (Fig. 1B, 1C). Myogenin
expression (Fig. 1A, 1C) and myotube formation (Fig. 1B, 1C)
by MPCs were similar in coculture and with MP-conditioned
medium, indicating that MPs mainly exerted their effects on
myogenesis through soluble factors. The following experiments
were then performed with MP-conditioned media.
M2a MPs and M2c MPs Stimulate MPC Commit-
ment into Myocytes
Commitment into myocytes, which is the entry into terminal
differentiation, was analyzed through the expression of myo-
genin in low-density cell cultures, to prevent migration/fusion
of the cells. M1 MP-conditioned medium did not alter the
expression of myogenin by MPCs while M2a MP- and M2c
MP-conditioned media strongly increased myogenin expres-
sion, by 2.7- and 4.2-fold, respectively (p < .05) (Fig. 2).
These data show that M2a MPs and M2c MPs stimulate the
differentiation of MPCs into myocytes.
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M1 MPs Stimulate MPC Motility
Figure 3A shows that a M1 MP-conditioned medium did not
alter MPC motility compared to untreated cells. However, the
speed of the cells was lower under M2a MP- and M2c MP-
conditioned media (22%–24% less, p < .05). The median ve-
locity was lower in cells treated with M2a MP- and M2c MP-
conditioned medium (Fig. 3B). Mean velocities of the cell
populations above and below the median were also decreased
(data not shown), indicating a decreased motility of the entire
MPC population and not of a subset of MPCs.
M1 MPs Do Not Attract MPCs While They Migrate
Toward MPCs
Cell migration toward a gradient/other cell type was analyzed
in a double chamber silicone device (Fig. 3C). Under M2a
MP- and M2c MP-conditioned media, MPCs displayed the
same degree of migration as toward other MPCs, while their
migration toward M1 MPs was much lower (45%, p < .05)
(Fig. 3D). Conversely, when examining MP migration, M1
MPs were strongly attracted by MPCs, compared to M2a
MPs and M2c MPs (Fig. 3E) (2.5 and twofold, respectively,
p < .05).
M1 MPs Inhibit MPC Fusion
Already differentiated myocytes (preventing the differentia-
tion parameter) were plated at high density (preventing the
migration parameter) in MP-conditioned media to evaluate
fusion after desmin immunolabeling (Fig. 4A). Fusion index
was strongly decreased in MPCs cultured with M1 MP-con-
ditioned medium (63%, p < .05) (Fig. 4B). The myotube
distribution was significantly different under all MP condi-
tions tested compared to MPC alone (p < .05). In particu-
lar, M1 MP-conditioned medium inhibited the formation of
large myotubes (75% inhibition for myotubes containing
more than 10 nuclei, p < .05) while the formation of small
myotubes (three to five nuclei) was unaffected (Fig. 4C). As
a whole, the fusion index of MPCs was not affected by
M2a MP- and M2c MP-conditioned media (Fig. 4B). How-
ever, the distribution of myotubes was significantly different
from that of MPCs cultured alone (both p < .05). M2c
MP-conditioned medium stimulated the formation of large
myotubes (68% of increase for myotubes more than 10
nuclei, p < .05) (Fig. 4C). Similarly, M2a MP-conditioned
medium stimulated the formation of large myotubes (52%, p
< .05) (Fig. 4C). In both cases, the formation of small
myotubes was not altered. These results suggest that acti-
vated MPs differentially control the formation of mature
myotubes.
Effectors Secreted by Activated MPs Regulate In
Vitro Myogenesis
Some MP-released effectors are known or believed to have an
impact on MPCs. However, the role of these effectors in the
regulation of myogenesis through secretion by MPs has not
been established. We tested the involvement of a series of
seven molecules in the regulation of myogenesis by MPs
through the use of blocking antibodies. Blocking IL-6 (Fig.
5A) increased myotube formation (by 38%, p < .05) only in
MPCs cultured with M1 MP-conditioned medium. Blocking
IL-1b similarly increased myotube formation only in MPCs
cultured with M1 MP-conditioned medium (þ49%, p < .05)
(Fig. 5B). The blockade of VEGF (Fig. 5C) increased myo-
tube formation in MPCs treated with all MP-conditioned
media, although the effect was more pronounced for M1 MPs
(þ58%, þ20%, and þ26% for M1 MPs, M2a MPs, and M2c
MPs, respectively, all p < .05). As TNFa is known to have
differential effects on myogenesis depending on its concentra-
tion [32], we used two dilutions of blocking antibodies (Fig.
5D). At a low dilution, anti-TNFa decreased myotube forma-
tion in M2a MP- and M2c MP-conditioned medium-treated
MPCs (30 and 31%, p < .05) while it had no effect on M1
MP-conditioned medium-treated cells (Fig. 5D, white bars).
At a higher concentration, anti-TNFa still decreased myotube
formation in M2a MP- and M2c MP-conditioned medium-
treated cells—to the same extent (p < .05)—and increased
myotube formation of MPCs incubated with M1 MP-condi-
tioned medium (þ27% of fusion, p < .05) (Fig. 5D, gray
bars). Blockade of the TNFa-family member TWEAK did not
affect the formation of myotubes by MPCs in all conditions
(Fig. 5E). Anti-IL-13 antibodies induced an increase of myo-
tube formation in MPCs cultured only in the presence of M1
MP-conditioned medium (þ50%, p < .05) (Fig. 5F). Adding
blocking anti-TGFb antibodies significantly reduced the for-
mation of myotubes in MPC cultures treated with M2a MP-
Figure 2. Effects of MPs on myogenic precursor cell (MPC) commitment into myocytes. MPCs were cultured at low density with or without
conditioned medium from M1 MPs, M2a MPs, or M2c MPs for 3 days. (A): MPCs were immunolabeled for desmin (red) and myogenin (green)
(blue ¼ Hoechst). Bar ¼ 50 lm. (B): The number of myogeninpos nuclei is expressed as a percentage of total nuclei. Results are means 6 SEM
of three independent experiments. *, p < .05 versus none and versus M1 MPs. Abbreviation: MP, macrophage.
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and M2c MP-conditioned media (26% and 27%, respec-
tively, p < .05) (Fig. 5G). Except for the TWEAK antibody,
none of these blocking antibodies affected the formation of
myotubes by MPCs cultured alone (Fig. 5H). Although it is
known that MPCs synthesize some of these cytokines and
growth factors [33, 34], MPs secrete much higher levels of
these compounds [11, 26]. These results show that effectors
differentially secreted by activated MPs regulate myotube for-
mation according to the state of activation of MPs.
During In Vivo Human Muscle Regeneration, MPs
Sequentially Express Proinflammatory and Anti-
Inflammatory Markers and Are Associated with
Proliferating and Differentiating MPCs, Respectively
To explore inflammation during in vivo human muscle regen-
eration, we used a protocol combining lengthening contrac-
tions and electrostimulation [20]. This resulted in myofiber
damage, and the kinetics of tissue repair can be followed
Figure 3. Effects of MPs on MPC motility and migration. (A, B): MPCs were cultured with or without conditioned medium from M1 MPs,
M2a MPs, or M2c MPs and observed for 16 hours. Individual cell trackings were followed with Image J software and the velocity for each cell
was calculated. (A): Mean velocity of whole MPC population is expressed in lm/minute. (B): Boxes represent the velocity of total cell popula-
tion (min to max), with the median. Results are means 6 SEM of three independent experiments. *, p < .05 versus none and versus M1 MPs.
(C--E): MPCs and MPs (M1 MPs, M2a MPs, or M2c MPs) were cultured in two-chamber devices (C, here as an example, MPCs and M2a MPs)
so the two cell types faced each other, allowing migration toward each other over a 24 hours period. Pictures were taken at 0 and 24 hours. A
virtual line was drawn on the picture at the cell front at time 0 and copied to the picture at time 24 hours. Individual cell migration was calcu-
lated from this line. Individual cell migration of MPCs toward activated MPs (D) and of MPs toward MPCs (E) is expressed in lm. Results are
means 6 SEM of four independent experiments. *, p < .05 versus MPCs in (D) and versus M1 MPs in (E). Abbreviations: MP, macrophage;
MPC, myogenic precursor cell.
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during the ensuing muscle regeneration. Supporting informa-
tion Figure S2 shows that in normal untreated human muscle
(day 0), CD56-positive cells (CD56pos) were observed
throughout the muscle, at the normal place of satellite cells,
while no staining was observed for the embryonic form of
myosin heavy chain, which is a characteristic of regenerated/
regenerating myofibers [35]. On day 7 after the damage
induction, the myogenic marker CD56 stained numerous areas
while embryonic myosin heavy chain stained several regener-
ating myofibers (supporting information Fig. S2, day 7).
These areas associated with CD56pos cells and young new
myofibers were observed in regions of damaged myofibers
and where regeneration took place. These regions, which we
called regenerating areas, were distributed throughout the
muscle biopsy cross-section (supporting information Fig. S2,
day 7). On day 30 after damage, the muscle had recovered its
normal histology, except for very rare myofibers with a cen-
trally located myonucleus (supporting information Fig. S2,
day 30). That the dynamic processes of damage and regenera-
tion can be followed so clearly in this model makes it suitable
for studying the relationship between MP activation and myo-
genesis in vivo.
To assess MP activation in vivo, we analyzed on serial
sections the expression of various proinflammatory and anti-
inflammatory markers, together with myogenic markers, dur-
ing normal human skeletal muscle regeneration. Pax7 is a
transcription factor expressed by quiescent and cycling, but
not differentiating, MPCs. CD56 is expressed by quiescent,
cycling, differentiating MPCs, and young regenerated myofib-
ers. Myogenin is a transcription factor only expressed by differ-
entiating myogenic cells. In human, CD68 is believed to widely
label MPs while expression of CD206 and CD163 has been
associated with anti-inflammatory phenotypes. When expressed
by MPs, iNOS and COX2 are proinflammatory markers while
Arg1 is expressed by M2a MPs [14, 15].
In normal muscle at steady state, almost no CD56pos
cells were ki67pos indicating that they were quiescent (Fig.
6, day 0), as previously reported [18]. As expected, no
labeling for myogenin was observed (data not shown). Few
cells were observed in the interstitial space that were posi-
tive for CD68, CD206, or CD163; no positivity was
observed for iNOS, COX2, or Arg1 (Fig. 6, day 0). At day
7 after damage, numerous regenerating areas were present,
containing proliferating cells (ki67posCD56pos) and/or differ-
entiating cells (myogeninpos) (Fig. 6, day 7, Fig. 7). The
vast majority (more than 80%) of the regenerating areas was
associated with MPs that were positive for proinflammatory
and for anti-inflammatory markers. Less than 20% of the
regenerating areas were associated with only one type of
MPs: 17% contained MPs expressing only anti-inflammatory
markers while 0.4%–2% was associated with only proinflam-
matory MPs (when considering three and two markers,
respectively). This suggests that MPs expressing proinflam-
matory and anti-inflammatory markers coexisted in the same
regenerating areas. To analyze whether early and later regen-
erating areas were preferentially associated with different
types of MPs, they were divided according to the absence
(approximately 28% of the total regenerating areas) or the
presence (approximately 72%) of myogeninpos cells, inde-
pendently of the number of myogeninpos cells. The number
of MPs per myofiber did not differ between myogeninpos-
and myogeninneg-containing regenerating areas. An MP/MPC
ratio of 2.5 6 0.7 was found in regenerating areas, the me-
dian being 1.8 (the absolute range was from 0 to 12 MPs/
area). When the regenerating areas were divided according
to the presence or absence of myogeninpos cells, MP inflam-
matory markers were segregated (Fig. 6, day 7, Fig. 7). Proin-
flammatory markers such as iNOS and COX2 were expressed
by more MPs in regenerating areas containing only myogenin-
neg cells compared to those containing at least one myogeninpos
Figure 4. Effects of MPs on myogenic precursor cell (MPC) fusion. Differentiated MPCs (myocytes) were cultured at high density with or
without conditioned medium from M1 MPs, M2a MPs, or M2c MPs for 3 days. (A): MPCs were immunolabeled for desmin (red) (blue ¼
Hoechst). Bar ¼ 50 lm. Myotubes were counted and classified according to their number of nuclei. (B): Fusion index is expressed in %. (C):
Each class of myotubes is expressed as percentage of total myotubes. Results are means 6 SEM of three independent experiments. *, p < .05
versus none. Abbreviation: MP, macrophage.
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MPC: 51.3% versus 22.2% and 44.6% versus 18.6%, respec-
tively (p < .05) (Fig. 6, day 7, Fig. 7). Conversely, Arg1-
expressing MPs were more numerous in regenerating areas con-
taining myogeninpos MPCs, compared to those without differ-
entiating MPCs: 52.8% versus 30.9% (p < .05) (Fig. 6, day 7,
Fig. 7). The actual expression of iNOS, COX2, and Arg1 by
CD68 MPs was assessed by confocal microscopy (Fig. 7).
Immunostainings showed that most of the regenerating areas
contained MPs expressing CD206 and CD163. However, regen-
erating areas containing myogeninpos MPCs were associated
with 1.8-fold more CD206pos MPs and CD163pos MPs (p < .05)
(Fig. 6, day 7, Fig. 7). It has been shown that murine myogenic
cells express CD206 [36]. Colabeling of regenerating human
muscle with CD68 and CD206 showed that almost all CD206pos
cells observed in the regenerating areas were costained with
CD68 indicating their macrophagic origin (supporting informa-
tion Fig. S3). Thirty days after damage, no cycling or differenti-
ating cells were observed (Fig. 6, day 30). With regard to the
untreated muscle at day 0, few MPs expressing CD68, CD206,
or CD163 were observed between the myofibers, and they did
not express iNOS or COX2. Some MPs expressed Arg1 (Fig. 6,
day 30). Taken together, these data reveal that different MP
Figure 5. Macrophages (MPs) exert their effect through a series of secreted effectors. Myogenic precursor cells (MPCs) were cultured with or
without conditioned medium from with M1 MPs, M2a MPs, or M2c MPs in the absence (black bars) or the presence (white bars) of blocking
antibodies directed against IL-6 (A), IL-1b (B), VEGF (C), TNFa (D), antibody was used at 1/1,000 (white bars) and 1/100 (gray bars), TWEAK
(E), IL-13 (F), and TGFb (G). Three days later, MPCs were immunolabeled for desmin and the number of myotubes was calculated as a percent-
age of desminpos cells. (H): MPCs were incubated without MP-conditioned medium in the presence of the blocking antibodies. Results are means
6 SEM of at least three independent experiments. *, p < .05 versus control (medium without antibodies, black bars). Abbreviations: TGF, trans-
forming growth factor; TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor; IL, interleukin.
Saclier, Yacoub-Youssef, Mackey et al. 391
www.StemCells.com
subsets are preferentially associated with areas containing pro-
liferating or differentiating MPCs.
DISCUSSION
This study shows for the first time in human that MPs differ-
entially act on MPCs depending on their activation/polariza-
tion state. They exert these trophic roles through the secretion
of a series of cytokines and growth factors, thereby control-
ling the fate of the muscle progenitors at each step of in vitro
myogenesis. We also show for the first time in human that
these in vitro-activated MPs correspond to MP subsets in
vivo. Indeed, during human muscle regeneration, regenerating
areas are first preferentially associated with MPs bearing
proinflammatory markers. Then, at the time of myogenic dif-
ferentiation, MPs expressing anti-inflammatory markers are
preferentially found in the regenerating areas.
Trophic activities for MPs have recently emerged in vari-
ous contexts of tissue development, morphogenesis, and
angiogenesis [37, 38]. In normal adult tissues, recent advances
have been made in identifying supportive roles for MPs in
stem cell homeostasis. MPs promote erythroblast survival and
differentiation through very late activation antigen 4 and
CD163 [39–41]. MPs support stem cell homeostasis in the
bone marrow, and in intestinal and mammary epithelia
[42–45]. In the nervous system, microglia rescues neurogene-
sis in neural stem cells by the secretion of neurogenic factors
[46]. MPs deliver anti-inflammatory cues beneficial to spinal
cord recovery [47]. They secrete TGFb which promotes oligo-
dendrocyte differentiation and myelinogenesis [48]. Microglia
activated by proinflammatory cues block neural progenitor
differentiation while IL-4-activated microglia stimulates the
formation of oligodendrogenesis, possibly through the produc-
tion of IGF-1 [16, 49]. In skeletal muscle, we have shown in
vitro that MPs rescue MPCs from apoptosis and stimulate
their growth and proliferation through a panel of secreted and
membrane-bound effectors [25, 33].
In our in vitro coculture system, based on a 1:3 MP/MPC
ratio, we here showed that MPs mainly exerted their effects
on myogenesis through the secretion of soluble factors. We
have previously shown in vitro that M1 MPs stimulate MPC
proliferation while M2a MPs and M2c MPs do not [11].
Here, we explored each step of in vitro myogenesis using an
experimental setup that allows for analysis of each step inde-
pendently of the others: commitment into myocyte, migration
and fusion [36]. During in vitro myogenesis, MPCs migrate to
the injured area and then toward each other in order to form
myotubes. Differentiating and differentiated MPCs express a
wide range of chemokine receptors that bind to chemokines
in a redundant way [50]. Activated MPs have been shown to
secrete specific panels of chemokines [14, 15] and likely other
attracting molecules. Chemotaxis is a global integrated cell
response to signaling by several individual receptors. There-
fore, it is difficult to decipher which signals secreted by MPs
govern MPC motility and chemotaxis. However, our results
present a new property of human MPs in the regulation of
progenitor motility. M2c MPs and M2a MPs were observed
to decrease the motile properties of MPCs and were better at-
tractants for MPC directional migration. We have previously
shown in vitro that MPCs attract circulating monocytes [33].
It is therefore tempting to propose, knowing that M1 MPs are
the first to enter the damaged muscle in mouse [11], that
monocyte-derived M1 MPs have a great migratory capacity
toward MPCs at the beginning of muscle regeneration. It can
be hypothesized that these M1 MPs would maintain MPC mi-
gratory capacities thus preventing fusion from occurring too
early, a high migratory speed being detrimental for good
fusion [51]. M2a MPs and M2c MPs would further attract
MPCs, decrease their motility, thus favoring contact between
cells, and deliver prodifferentiating cues. Further analyses are
required to confirm these hypotheses.
Myogenic commitment into myocytes is the expression of
the myogenic program after cell-cycle withdrawal and pre-
cedes fusion, which is the last step of in vitro myogenesis. In
all the functional assays we tested in vitro, M2a MPs and
M2c MPs displayed opposing effects to those of M1 MPs.
M1 MPs inhibited MPC fusion, particularly the formation of
large myotubes while M2a MPs and M2c MPs strongly
Figure 6. Kinetics of myogenic and macrophage (MP) markers dur-
ing human skeletal muscle regeneration. Serial sections from control
(day 0) and electrostimulated human muscle at day 7 and day 30 after
electrostimulation were stained for various myogenic (CD56 and
myogenin) and MP (CD68, CD206, and CD163) markers. ki67 labels
cycling cells, laminin labels the basal membrane, COX2, iNOS, and
Arg1 expression is associated with various states of MP activation.
Arrows indicate regenerating areas that do not contain myogeninpos
cells; arrowheads indicate regenerating areas that contain at least one
myogeninpos cell. Bar ¼ 50 lm. Pictures are representative of three
independent experiments.
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stimulated the commitment of MPCs into myocytes and pro-
moted the formation of large myotubes. Our results suggest
that the formation of nascent myotubes is not controlled by
MP-conditioned media. Most of the molecular systems
involved in prefusion migration and myocyte fusion are trans-
membrane proteins and a few soluble effectors have been
identified [52]. Among them IL-4 is involved in the formation
of mature myotubes in mouse [53]. IL-4 production by lung
MPs has been associated with the presence of M2a MPs [54,
55]. IL-4 may, therefore, be one of the effectors of the stimu-
lation of fusion by M2a MPs and M2c MPs.
Few molecules that can account for the effects of MPs on
muscle precursors are known. Recent work in mouse showed
that Granulocyte-Colony Stimulating Factor (G-CSF) is bene-
ficial to skeletal muscle regeneration by stimulating MPC pro-
liferation [56]. This study did not explore which cells were
the source of G-CSF. However, MPs secrete G-CSF, particu-
larly M1 MPs, and G-CSF has been shown to be associated
with inflammation and activation by Th-1 cytokines [57, 58].
Exploring the role of CCR2 expressed by MPs, Lu et al. [59]
have shown that MPs are likely to be the main source of IGF-
1 in regenerating muscle; they further showed that the
Figure 7. Association of differentially activated macrophages (MPs) with regenerating areas during skeletal muscle regeneration in human. Se-
rial sections of human muscle on day 7 after electrostimulation were stained for various myogenic (Pax7, CD56, and myogenin) and MP (CD68,
CD206, and CD163) markers. ki67 labels cycling cells; laminin labels the basal membrane; COX2, iNOS, and Arg1 expression is associated with
various states of MP activation. Arrows indicate regenerating areas that do not contain myogeninpos cells; arrowheads indicate regenerating areas
that contain at least one myogeninpos cell. Bottom panel: confocal analysis was performed to assess colocalization of COX2, iNOS, and Arg1 in
CD68pos cells. Bar ¼ 50 lm. Histograms on the right panel display the percentage of iNOSpos (A), COX2pos (B), Arg1pos (C), CD68pos cells in
regenerating areas containing (w myogþ) or not containing (w/o myogþ) myogeninpos cells. (D) and (E) show the number of CD206pos (D) and
CD163pos (E) cells in regenerating areas containing (w myogþ) or not containing (w/o myogþ) myogeninpos cells. Results are means 6 SEM of
three independent experiments. *, p < .05.
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intramuscular Ly6Cneg MP subset, which presents an anti-
inflammatory profile, expresses high levels of IGF-1, which
promotes muscle repair. Here, we show the involvement of
several cytokines and growth factors in the regulation of myo-
genesis by activated MPs. The proinflammatory cytokines IL-
6 and IL-1b are mainly secreted by M1 MPs compared to
M2a MPs and M2c MPs [11, 26], and blocking IL-6 or IL-1b
affected only this MP subtype by increasing the formation of
myotubes. Accordingly, IL-6 has a proliferative effect on
MPCs [60, 61], while IL-1b has been shown to induce IL-6
production [62] and to reduce myogenic differentiation [63,
64]. TNFa is also produced in greater amounts by M1 MPs
[11, 26]. The effects of TNFa inhibition depended on the con-
centration of antibodies used, in accordance with the dose-de-
pendent effect of TNFa on muscle cell proliferation [32]. At
low concentrations, TNFa stimulates myogenic differentiation
[32]. Accordingly, decreased myotube formation was
observed upon TNFa inhibition of M2a MPs and M2c MP-
conditioned media, which contain low levels of TNFa. Con-
versely, high levels of TNFa stimulate myogenic cell prolifer-
ation [32] and M1 MPs increased myotube formation when
the cytokine was completely inhibited by blocking antibodies.
VEGF stimulates MPC growth [65] and differentiation [66,
67]. M1 MPs produce more VEGF than M2a MPs and M2c
MPs [26]. However, blocking VEGF induced an increase in
myotube formation in all conditions, suggesting that the effect
of VEGF on MPCs is mainly on cell growth. IL-13 regulates
the secondary recruitment of reserve cells into myotubes, par-
ticularly on IGF-1-stimulated human cells [68] and increases
fusion into myotubes [69]. Unexpectedly, blocking IL-13
induced increased myotube formation in MPCs cultured with
M1 MP-conditioned medium, suggesting that IL-13 partici-
pates in the nondifferentiating property of M1 MPs. TGFb is
expressed to a greater extent by M2a MPs and M2c MPs
[11]. TGFb inhibits cell myogenesis at the time of differentia-
tion [70–72] while it decreases cell growth and activates myo-
genesis when added to proliferating myoblasts [73]. Here,
TGFb participated in the prodifferentiating cues delivered by
M2a MPs and M2c MPs to MPCs since its blockade reduced
myotube formation in these two conditions. These results
identify an initial series of effectors differentially secreted by
activated MPs which are involved in the regulation of in vitro
myogenesis through their effects on MPCs.
It is likely that the MP activation states used for in vitro
studies are not fully representative of MP subsets found in
vivo [14, 74]. Therefore, we followed, to our knowledge for
the first time in human, the regeneration of skeletal muscle in
muscle biopsies obtained from healthy young men who had
performed maximal lengthening contractions of the quadriceps
muscles—a model that has previously been used in many
human studies of muscle damage [21, 75-77]. However, not
all studies using this model have observed damage in muscle
biopsies collected in the days after exercise [20, 78]. Further-
more, in a previous study [20], electrical stimulation was
reported to result in greater muscle damage than voluntary
contractions. In light of this, and in order to ensure initiation
of damage and regeneration processes, we increased the load
delivered to the muscle by electrically stimulating the vastus
lateralis muscle while the subject was contracting the muscle
voluntarily. Analysis of muscle biopsies collected before and
after this stimulus to the muscle enables distinct muscle re-
generative events to be followed clearly in humans in vivo.
We investigated the expression of a series of MP markers,
together with myogenic markers, during the time course of
regeneration in human muscle. The first lesson from this study
is that MP subsets cannot definitively be identified by a sole
marker, and that multiple labelings are required to attempt to
define MP subsets in vivo. We analyzed the expression of
iNOS, COX2, and Arg1 by CD68pos cells. Colabeling and
analysis at the single-cell level are necessary since many
other cells, including endothelial cells, interstitial cells, and
myogenic cells, also express these molecules [79–81]. CD206
and CD163 are considered as markers for anti-inflammatory
subsets (supporting information Fig. S1). Careful examination
of the immunostainings showed that several levels of fluores-
cence brightness were observed for these markers (data not
shown), in accordance with their increased expression by anti-
inflammatory MPs [82, 83]. The second lesson from this se-
ries of experiments is conceptual. Our results clearly show
that, according to the six markers used here to identify MPs
in vivo, several subsets of MPs are present in the same areas
at the same time. These results argue against the overly sim-
plistic view that a biological event is associated with one type
of MPs. Also found in the same regenerating areas were cy-
cling myogenic cells (CD56pos or Pax7pos ki67pos) together
with differentiating cells (myogeninpos). Therefore, although
general conclusions regarding the time course of some major
biological events can be drawn, one must keep in mind that
these events spatially and temporally overlap.
We present here the first time course of analysis of
inflammation during human skeletal muscle regeneration. Our
results confirm that both in normal muscle and once regenera-
tion is completed, almost no MP is present in the muscle
parenchyma. Regenerating areas are associated with MPs, the
vast majority (more than 80%) being associated with MPs
expressing proinflammatory and anti-inflammatory markers.
However, despite this complex situation, our analysis depicts
a time course of inflammation during human skeletal muscle
repair that resembles what has been observed in mouse [11,
84]. When analyzing regenerating areas on the basis of whether
they did or did not contain myogeninpos cells, a segregation in
MP distribution was observed. Regenerating areas that con-
tained only myogeninneg cells were preferentially associated
with MPs expressing proinflammatory markers. Conversely,
regenerating areas containing at least one myogeninpos cell
were preferentially associated with MPs expressing anti-inflam-
matory markers. The evidence of such localization indicates
privileged interactions between the two cell types and argues
for a synchronous regulation of adult myogenesis and inflam-
mation during muscle repair. The distinction between M2a MPs
and M2c MPs during muscle regeneration is not yet clear. It is
likely that the so-called anti-inflammatory subset(s) include(s)
some MPs that stimulate matrix remodeling and deposition
(thus resembling M2a MPs). Perdiguero et al. [84] showed that
three MP subsets are successively present during muscle repair:
inflammatory MPs, anti-inflammatory MPs, and a deactivated
MP subset associated with the last steps of muscle repair. ‘‘Ca-
nonical’’ M2a MPs have been identified under very specific
conditions, that is, parasitic challenge; it is therefore not known
whether this type of MPs may be also—even transiently—pres-
ent during normal tissue repair.
CONCLUSIONS
Combining our in vivo and in vitro data indicates that human
skeletal muscle regeneration is sequentially associated with
several MP subsets. Furthermore, we provide evidence of new
functions of MPs in the coordinated regulation of MPC fate
during muscle repair. In vivo analyses in a model of skeletal
muscle regeneration in the healthy adult revealed that regener-
ating areas at the time of MPC proliferation are associated with
M1 MPs, while in vitro experiments accordingly showed that
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M1 MPs migrate toward MPCs, stimulate their proliferation,
and prevent premature differentiation through the secretion of
IL-6, IL1-b, high TNFa, VEGF, and IL-13. In vivo immunos-
tainings showed that later, at the time of terminal differentia-
tion, regenerating areas are associated with M2c MPs and/or
M2a MPs. In line with this, in vitro experiments showed that
M2a MPs and M2c MPs attract MPCs and promote in vitro
myogenesis by stimulating their commitment into myocytes
and the formation of mature myotubes, through the secretion of
TGFb and low TNFa. Thus, MPs orchestrate an effective skele-
tal muscle repair process by finely tuning the sequential steps of
adult myogenesis. These results strengthen the emerging con-
cept that inflammation regulates stem cell homeostasis.
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